freemultihandvideopokernodownload| Clinical trials of radiotherapy drugs approved by Dongcheng Pharmaceutical subsidiary: cumulative research and development expenses are approximately 12.8227 million yuan

News summary

Dongcheng Pharmaceutical subsidiary is approved by the State Food and Drug Administrationfreemultihandvideopokernodownload, clinical trials of 177Lu-LNC 1010 injection will be launched soonfreemultihandvideopokernodownloadAs a targeted drug for the treatment of specific neuroendocrine tumors, competition in the global market is limited, and the cumulative investment in research and development has reached approximately 1,282freemultihandvideopokernodownload.270,000 yuan.

Newsletter text

[Dongcheng Pharmaceutical's holding subsidiary has been approved for clinical trials, paying attention to the dynamics of 177Lu-LNC 1010 injection] Dongcheng Pharmaceutical recently disclosed that its holding subsidiary Yantai Lannacheng Biotechnology Co., Ltd. has been approved and issued by the State Food and Drug Administration. Approval Notice for Clinical Trial of 177Lu-LNC 1010 injection. It is reported that the product is expected to undergo clinical trials soon. 177Lu-LNC1010 injection, a radioactive in vivo therapeutic drug targeting somatostatin receptor 2, is mainly suitable for the treatment of patients with somatostatin receptor 2-positive gastrointestinal and pancreatic neuroendocrine tumors. Currently, only Novartis's Lutathera has the same target as this drug, and its sales performance in 2023 will reach 6.5%.freemultihandvideopokernodownload.05 billion US dollars. In terms of R & D investment, Dongcheng Pharmaceutical has so far invested a total of approximately 12.8227 million yuan in 177Lu-LNC 1010 injection-related projects. The company emphasized that although the process from drug research and development to marketing is long and full of uncertainties, Dongcheng Pharmaceutical will make unremitting efforts to promote the progress of the project and will continue to update the research and development trends to the outside world.

Tags:

Prev: gamecryptoaxie| Jidian shares have a daily limit: CITIC Construction Investment Group bought a seat and won 176 million yuan, with a turnover rate of 6.79%
Next: freecoinsforjackpotpartycasino| Intelligent engine Chatimg's multimodal large model and multimodal agents appear at the 7th Digital China Construction Summit